0001209191-22-004632.txt : 20220124
0001209191-22-004632.hdr.sgml : 20220124
20220124170528
ACCESSION NUMBER: 0001209191-22-004632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220121
FILED AS OF DATE: 20220124
DATE AS OF CHANGE: 20220124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERMAN JEFFREY W
CENTRAL INDEX KEY: 0001230482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 22550193
MAIL ADDRESS:
STREET 1: C/O IDM PHARMA, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-21
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001230482
SHERMAN JEFFREY W
C/O HORIZON THERAPEUTICS PLC,
70 SAINT STEPHEN?S GREEN
DUBLIN
L2
D02 E2X4
IRELAND
0
1
0
0
EVP and Chief Medical Officer
Ordinary Shares
2022-01-21
4
M
0
5354
0.00
A
61665
D
Ordinary Shares
2022-01-21
4
F
0
2372
86.42
D
59293
D
Ordinary Shares
105808
I
See footnote
Ordinary Shares
66730
I
By Spouse
Restricted Stock Units (RSUs)
2022-01-21
4
M
0
5354
0.00
D
2022-01-21
2022-01-21
Ordinary Shares
5354
0
D
The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.
Each RSU represents a contingent right to receive one ordinary share of the Issuer.
/s/ Miles W. McHugh, Attorney-in-Fact
2022-01-24